Status:

TERMINATED

Comparison of EVD Catheter Diameter on Occlusion and Replacement

Lead Sponsor:

Wake Forest University Health Sciences

Conditions:

Occlusion

Eligibility:

All Genders

18-85 years

Phase:

NA

Brief Summary

A randomized trial comparing small versus large catheters in terms of occlusion and need for replacement to confirm differential occlusion risk based on catheter size. This study will be done to deter...

Detailed Description

Ventriculostomy is a common neurosurgical procedure. A Nationwide Inpatient Sample (NIS) database study demonstrated a significant increase in ventriculostomy utilization from 1988-2010, with over 35,...

Eligibility Criteria

Inclusion

  • Adult patients (18-85 years old) with a Glasgow Coma Scale (GCS) score of 7 or higher requiring frontal EVD placement.
  • Diagnoses: spontaneous subarachnoid hemorrhage, intraventricular hemorrhage, intraparenchymal or cerebellar hemorrhage due to aneurysm, arteriovenous malformation, arteriovenous fistula, hypertension, or idiopathic etiology.
  • Also included are patients for whom the attending neurosurgeon decides that frontal EVD placement is indicated for patient treatment with planned cerebrospinal fluid (CSF) drainage for 72 hours or more.

Exclusion

  • GCS of 6 or less
  • Hunt and Hess subarachnoid hemorrhage grade of 5.
  • Age 86 or greater, or age 17 or less.
  • Patient cannot consent and next of kin cannot consent prior to procedure.
  • Diagnosis of traumatic brain injury, as the EVD is often clamped for extended periods of time.
  • Patients anticoagulated prior to admission with warfarin, Effient, Plavix, therapeutic heparin infusion, therapeutic subcutaneous lovenox, therapeutic subcutaneous arixtra, or other therapeutic anticoagulant or antiplatelet agent (ASA not included).
  • Plan for EVD placement through non-frontal burr hole.

Key Trial Info

Start Date :

June 12 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 4 2022

Estimated Enrollment :

33 Patients enrolled

Trial Details

Trial ID

NCT03248739

Start Date

June 12 2017

End Date

November 4 2022

Last Update

October 25 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Wake Forest Baptist Health

Winston-Salem, North Carolina, United States, 27104